Publications dans lesquelles il/elle collabore avec ARANTXA ISLA RUIZ (26)

2024

  1. Streptococcus pneumoniae eta Haemophilus influenzae bakterio-espezieek eragindako infekzio inbaditzaile eta ez-inbaditzaileak: txertaketaren eraginak

    Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria, Núm. 45, pp. 71-92

2023

  1. Ceftaroline and Avibactam Removal by Continuous Renal Replacement Therapies: An in vitro Study

    Blood Purification, Vol. 52, Núm. 5, pp. 464-473

  2. Extended infusion of piperacillin/tazobactam: pharmacokinetics in critically ill patients

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  3. Pharmacokinetic/Pharmacodynamic Analysis of Oral Calcium Fosfomycin: Are Urine Levels Sufficient to Ensure Efficacy for Urinary Tract Infections?

    Pharmaceutics, Vol. 15, Núm. 4

2021

  1. Evaluation of the adequacy of the antimicrobial therapy of invasive Haemophilus influenzae infections: A pharmacokinetic/pharmacodynamic perspective

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 39, Núm. 2, pp. 65-71

  2. Oral calcium fosfomycin: Pharmacokinetic/pharmacodynamic study

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 76-78

  3. Pharmacokinetic/pharmacodynamic evaluation of the antimicrobial therapy of pneumococcal invasive disease in adults in post-PCV13 vaccine period in Madrid, Spain

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 40, Núm. 10, pp. 2145-2152

  4. Pseudomonas aeruginosa susceptibility in spain: Antimicrobial activity and resistance suppression evaluation by pk/pd analysis

    Pharmaceutics, Vol. 13, Núm. 11

  5. Quantification of ceftaroline in human plasma using high‐performance liquid chromatography with ultraviolet detection: Application to pharmacokinetic studies

    Pharmaceutics, Vol. 13, Núm. 7

2019

  1. Application of pharmacokinetic/pharmacodynamic analysis to evaluate the adequacy of antimicrobial therapy for pediatric acute otitis media in Spain before and after the introduction of the PCV7 vaccine

    Revista Espanola de Quimioterapia, Vol. 32, Núm. 2, pp. 121-129

  2. Pharmacokinetic/pharmacodynamic analysis as a tool for surveillance of the activity of antimicrobials against Pseudomonas aeruginosa strains isolated in critically ill patients

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 37, Núm. 6, pp. 380-386

  3. Pharmacokinetics of linezolid in critically ill patients on continuous renal replacement therapy: Influence of residual renal function on PK/PD target attainment

    Journal of Critical Care, Vol. 50, pp. 69-76

  4. Susceptibility of Pseudomonas aeruginosa and antimicrobial activity using PK/PD analysis: an 18-year surveillance study

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 37, Núm. 10, pp. 626-633

2016

  1. Meropenem dosing requirements against Enterobacteriaceae in critically ill patients: influence of renal function, geographical area and presence of extended-spectrum β-lactamases

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 35, Núm. 3, pp. 511-519

2015

  1. Pharmacokinetic/pharmacodynamic analysis to evaluate ceftaroline fosamil dosing regimens for the treatment of community-acquired bacterial pneumonia and complicated skin and skin-structure infections in patients with normal and impaired renal function

    International Journal of Antimicrobial Agents, Vol. 45, Núm. 4, pp. 399-405

2012

  1. Comparison of antimicrobial pharmacokinetic/pharmacodynamic breakpoints with EUCAST and CLSI clinical breakpoints for Gram-positive bacteria

    International Journal of Antimicrobial Agents, Vol. 40, Núm. 4, pp. 313-322

  2. Pharmacokinetic-pharmacodynamic evaluation of daptomycin, tigecycline, and linezolid versus vancomycin for the treatment of MRSA infections in four western European countries

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 31, Núm. 9, pp. 2227-2235

  3. Population pharmacokinetics of prophylactic cefoxitin in patients undergoing colorectal surgery

    European Journal of Clinical Pharmacology, Vol. 68, Núm. 5, pp. 735-745

2011

  1. Pharmacokinetic/pharmacodynamic evaluation of amoxicillin, amoxicillin/clavulanate and ceftriaxone in the treatment of paediatric acute otitis media in Spain

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. 3, pp. 167-173

2009

  1. Impact of acute otitis media pathogen shifts on the clinical efficacy of several antibiotics: A therapeutic outcomes model

    Journal of Chemotherapy, Vol. 21, Núm. 4, pp. 408-413